Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

HIV tat and neurotoxicity.

King JE, Eugenin EA, Buckner CM, Berman JW.

Microbes Infect. 2006 Apr;8(5):1347-57. Epub 2006 Jan 26. Review.

PMID:
16697675
3.

Synaptic transport of human immunodeficiency virus-Tat protein causes neurotoxicity and gliosis in rat brain.

Bruce-Keller AJ, Chauhan A, Dimayuga FO, Gee J, Keller JN, Nath A.

J Neurosci. 2003 Sep 10;23(23):8417-22.

4.

HIV-tat induces formation of an LRP-PSD-95- NMDAR-nNOS complex that promotes apoptosis in neurons and astrocytes.

Eugenin EA, King JE, Nath A, Calderon TM, Zukin RS, Bennett MV, Berman JW.

Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3438-43. Epub 2007 Feb 21.

5.

MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis.

Eugenin EA, D'Aversa TG, Lopez L, Calderon TM, Berman JW.

J Neurochem. 2003 Jun;85(5):1299-311.

6.

Detection of the human immunodeficiency virus regulatory protein tat in CNS tissues.

Hudson L, Liu J, Nath A, Jones M, Raghavan R, Narayan O, Male D, Everall I.

J Neurovirol. 2000 Apr;6(2):145-55.

PMID:
10822328
7.

Silencing the PTEN gene is protective against neuronal death induced by human immunodeficiency virus type 1 Tat.

Zhao T, Adams MH, Zou SP, El-Hage N, Hauser KF, Knapp PE.

J Neurovirol. 2007 Apr;13(2):97-106.

PMID:
17505978
8.

EGCG mitigates neurotoxicity mediated by HIV-1 proteins gp120 and Tat in the presence of IFN-gamma: role of JAK/STAT1 signaling and implications for HIV-associated dementia.

Giunta B, Obregon D, Hou H, Zeng J, Sun N, Nikolic V, Ehrhart J, Shytle D, Fernandez F, Tan J.

Brain Res. 2006 Dec 6;1123(1):216-225. doi: 10.1016/j.brainres.2006.09.057. Epub 2006 Oct 31.

9.

Uptake of HIV-1 tat protein mediated by low-density lipoprotein receptor-related protein disrupts the neuronal metabolic balance of the receptor ligands.

Liu Y, Jones M, Hingtgen CM, Bu G, Laribee N, Tanzi RE, Moir RD, Nath A, He JJ.

Nat Med. 2000 Dec;6(12):1380-7.

PMID:
11100124
10.

Progress in understanding basal ganglia dysfunction as a common target for methamphetamine abuse and HIV-1 neurodegeneration.

Theodore S, Cass WA, Nath A, Maragos WF.

Curr HIV Res. 2007 May;5(3):301-13. Review.

PMID:
17504172
11.

Increased vulnerability of ApoE4 neurons to HIV proteins and opiates: protection by diosgenin and L-deprenyl.

Turchan-Cholewo J, Liu Y, Gartner S, Reid R, Jie C, Peng X, Chen KC, Chauhan A, Haughey N, Cutler R, Mattson MP, Pardo C, Conant K, Sacktor N, McArthur JC, Hauser KF, Gairola C, Nath A.

Neurobiol Dis. 2006 Jul;23(1):109-19. Epub 2006 May 11.

PMID:
16697650
12.
13.

HIV-dementia, Tat-induced oxidative stress, and antioxidant therapeutic considerations.

Pocernich CB, Sultana R, Mohmmad-Abdul H, Nath A, Butterfield DA.

Brain Res Brain Res Rev. 2005 Dec 1;50(1):14-26. Review.

PMID:
15890409
14.

Neuronal apoptosis in human immunodeficiency virus infection.

Gray F, Adle-Biassette H, Brion F, Ereau T, le Maner I, Levy V, Corcket G.

J Neurovirol. 2000 May;6 Suppl 1:S38-43. Review.

PMID:
10871764
15.

Novel insights into role of miR-320a-VDAC1 axis in astrocyte-mediated neuronal damage in neuroAIDS.

Fatima M, Prajapati B, Saleem K, Kumari R, Mohindar Singh Singal C, Seth P.

Glia. 2017 Feb;65(2):250-263. doi: 10.1002/glia.23089. Epub 2016 Oct 20.

PMID:
27761954
16.

Proteinase-activated receptor-2 induction by neuroinflammation prevents neuronal death during HIV infection.

Noorbakhsh F, Vergnolle N, McArthur JC, Silva C, Vodjgani M, Andrade-Gordon P, Hollenberg MD, Power C.

J Immunol. 2005 Jun 1;174(11):7320-9.

17.
18.

Interaction of HIV Tat and matrix metalloproteinase in HIV neuropathogenesis: a new host defense mechanism.

Rumbaugh J, Turchan-Cholewo J, Galey D, St Hillaire C, Anderson C, Conant K, Nath A.

FASEB J. 2006 Aug;20(10):1736-8. Epub 2006 Jun 28.

PMID:
16807369
19.

MH2 domain of Smad3 reduces HIV-1 Tat-induction of cytokine secretion.

Eldeen MB, Deshmane SL, Simbiri K, Khalili K, Amini S, Sawaya BE.

J Neuroimmunol. 2006 Jul;176(1-2):174-80. Epub 2006 Jun 5.

PMID:
16750572
20.

[HIV-1 neuropathogenesis: therapeutic strategies against neuronal loss induced by gp120/Tat glycoprotein in the central nervous system].

Merino JJ, Montes ML, Blanco A, Bustos MJ, Oreja-Guevara C, Bayon C, Cuadrado A, Lubrini G, Cambron I, Munoz A, Cebolla S, Gutierrez-Fernandez M, Bernardino JI, Arribas JR, Fiala M.

Rev Neurol. 2011 Jan 16;52(2):101-11. Review. Spanish.

Supplemental Content

Support Center